Immunology Focus Nielsen’s long-standing work with heterogeneous antigen profiles and cell-mediated immunity enables opportunities to offer custom antigen panel development, immune diagnostics, and adjunct immunotherapies to biotech and pharma partners seeking broad immune engagement.

Collaboration Readiness As a private company with 11-50 employees and 10-25 million in revenue, Nielsen is well positioned for R&D collaborations, licensing, or co-development deals that help de-risk and scale programs with larger partners.

CRO/CMO Potential The antigen-focused R&D needs point to possible CRO/CDMO partnerships for antigen production, assay development, and regulatory support to accelerate product development timelines.

Digital Marketing Nielsen’s tech footprint and Google Analytics usage offer a path to marketing enablement services—enhanced digital outreach, clinician education programs, and data-driven outreach to medical professionals and institutions.

San Diego Advantage Located in San Diego, Nielsen can leverage regional biotech ecosystems, academic collaborations, and local funding channels to accelerate partnerships, access talent, and advance clinical or preclinical programs.